×

BRIEF-Mitsubishi Tanabe Pharma Corp says RADICAVA to treat ALS will cost $1086 per infusion

$1086 per infusion@

May 5 (Reuters) - Mitsubishi Tanabe Pharma Corp:

* Mitsubishi Tanabe Pharma Corp says will offer co-pay assistance for commercially insured patients to help reduce their out-of-pocket costs

* Mitsubishi Tanabe Pharma corp says RADICAVA to treat patients with als will cost $1,086 per infusion, $11,194 per dosage cycle